Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2000
11/23/2000WO1999048482A3 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease
11/23/2000WO1999004775A3 Method of treating dopaminergic and gaba-nergic disorders
11/23/2000DE19923571A1 New plant promoter containing cis-acting elements, useful for producing transgenic plants with increased tolerance of pathogens, particularly fungi
11/23/2000DE19923568A1 Incorporating gcpE and yfgB genes into viruses and cells, for increasing isoprenoid content and identifying e.g. antimicrobial agents, comprises using DNA sequences from bacteria or parasites
11/23/2000DE19923168A1 Neue Fluoreszenzfarbstoffe und ihre Verwendung als Fluoreszenzmarker New fluorescent dyes and their use as fluorescent markers
11/23/2000DE19919124A1 Nukleinsäuremolekül, umfassend eine für ein Polypeptid mit Chorismatmutase-Aktivität kodierende Nukleinsäure Nucleic acid molecule comprising a sequence encoding a polypeptide having chorismate mutase activity nucleic acid
11/23/2000DE19918949A1 Überexpression einer DNA-Sequenz codierend für eine 1-Desoxy-D-Xylulose-5-Phosphat Reduktoisomerase in Pflanzen Over-expression of a DNA sequence encoding a 1-deoxy-D-xylulose-5-phosphate reductoisomerase in plants
11/23/2000DE19918446A1 Verwendung von Coxsackievirus B3 zur Verbesserung der Transfektion von Zellen Use of coxsackievirus B3 to improve the transfection of cells
11/23/2000DE10024247A1 Sample holder for biological analyses comprises different specific binding substances arranged on different layers of a substrate
11/23/2000CA2376722A1 Chloramphenicol biosynthetic pathway and gene cluster characterization
11/23/2000CA2374272A1 Promoter of thioredoxine tatrxh2 in wheat
11/23/2000CA2374235A1 Production of complex carbohydrates
11/23/2000CA2374053A1 Secreted polypeptides and corresponding polynucleotides
11/23/2000CA2374045A1 Compositions isolated from skin cells and methods for their use
11/23/2000CA2374015A1 Gene isolated from ricinus communis encoding a new protein that interacts with the oleate 12-hydroxylase enzyme
11/23/2000CA2373824A1 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus
11/23/2000CA2373616A1 Tm4sf receptors
11/23/2000CA2373243A1 Automated nucleic acid compaction device
11/23/2000CA2373231A1 Extracellular signaling molecules
11/23/2000CA2373191A1 Full-length molecules expressed in human tissues
11/23/2000CA2372926A1 143 human secreted proteins
11/23/2000CA2372783A1 Identifying material from a breast duct
11/23/2000CA2372667A1 Methods of detecting colorectal disease by conduction an assay to detect a mutation in a bat-26 locus
11/23/2000CA2372654A1 Acquired resistance genes in plants
11/23/2000CA2372582A1 Novel fab fragment libraries and methods for their use
11/23/2000CA2372556A1 Directed evolution of microorganisms
11/23/2000CA2372549A1 Ox2 receptor homologs
11/23/2000CA2372541A1 Sphingosine kinase enzyme
11/23/2000CA2372534A1 Differentiated human embryoid cells and a method for producing them
11/23/2000CA2372485A1 Cell concentration and lysate clearance using paramagnetic particles
11/23/2000CA2372435A1 Recombinant human mannan-binding lectin
11/23/2000CA2372393A1 Novel proteins with insulin-like activity useful in the treatment of diabetes
11/23/2000CA2372323A1 Methods for increasing plant cell proliferation by functionally inhibiting a plant cyclin inhibitor gene
11/23/2000CA2372304A1 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins
11/23/2000CA2372200A1 Self-assembling biomolecular structures
11/23/2000CA2372198A1 Protein scaffold and its use to multimerise monomeric polypeptides
11/23/2000CA2372163A1 A method and relational database management system for storing, comparing, and displaying results produced by analyses of gene array data
11/23/2000CA2372128A1 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals
11/23/2000CA2372119A1 Neuroprotective properties of gdf-15, a novel member of the tgf-.beta. superfamily
11/23/2000CA2372102A1 Lawsonia derived gene and related omph polypeptides, peptides and proteins and their uses
11/23/2000CA2372098A1 Lawsonia derived gene and related flge polypeptides, peptides and proteins and their uses
11/23/2000CA2372095A1 Lawsonia derived gene and related sodc polypeptides, peptides and proteins and their uses
11/23/2000CA2372054A1 Ph dependent ion exchange matrix and method of use in the isolation of nucleic acids
11/23/2000CA2372036A1 Compositions of solvents and high concentrations of nucleic acid analogs
11/23/2000CA2371212A1 Differential gene expression in specific regions of the brain in neurodegenerative diseases
11/23/2000CA2369376A1 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer and for prevention of cancer in at-risk subjects
11/23/2000CA2369369A1 Buforin 1 as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins
11/23/2000CA2368948A1 Envelope gene-deficient virus vector of paramyxoviridae
11/23/2000CA2368833A1 Molecules expressed in hippocampus
11/23/2000CA2368620A1 Genetic modification of male germ cells for generation of transgenic species and genetic therapies
11/22/2000EP1054064A1 Adenovirus derived gene delivery vehicles comprising at least one element of adenovirus type 35
11/22/2000EP1054063A2 Process for the production of naturally folded and secreted proteins
11/22/2000EP1054062A1 Glycosyltransferase and dna encoding the same
11/22/2000EP1054061A1 Protein standard, comprising at least one antibody-binding domain of streptococcal protein G
11/22/2000EP1054059A1 Novel cDNAs encoding catenin-binding proteins with function in signalling and/or gene regulation
11/22/2000EP1054058A1 Pharmaceutical composition for treatment of Duchenne muscular dystrophy
11/22/2000EP1054057A1 Mutagenesis method
11/22/2000EP1054056A1 Apparatus for immobilized dna library preparation, apparatus for gene amplification, method for temperature control and method for comparing genes systematically
11/22/2000EP1054039A1 Fluorescent dyes and their use as fluorescent labelling agents
11/22/2000EP1054018A1 Fab fragment libraries and methods for their use
11/22/2000EP1053677A1 Nonhuman animal embryonic stem cells and nonhuman animals having variant smooth muscle myosin heavy-chain genes
11/22/2000EP1053460A2 An automatic method of classifying molecules
11/22/2000EP1053357A1 Processes for isolating, amplifying and characterizing dna
11/22/2000EP1053356A2 Method for diagnosis and treatment of disorders of carbohydrate metabolism
11/22/2000EP1053353A1 Eluting reagents, methods and kits for isolating dna
11/22/2000EP1053352A1 Mismatch detection techniques
11/22/2000EP1053351A1 Novel molecules of the tnf receptor superfamily and uses therefor
11/22/2000EP1053350A1 Methods for dna amplification and sequencing
11/22/2000EP1053349A1 Methods for identifying therapeutic targets
11/22/2000EP1053347A1 Peptide detection method
11/22/2000EP1053343A2 Targeting of genetic vaccine vectors
11/22/2000EP1053342A2 Nucleic acid delivery vehicles
11/22/2000EP1053341A1 Use of negative regulation elements for nerve-specific expression of transgenes
11/22/2000EP1053340A1 Genetic manipulation of spermatogonia
11/22/2000EP1053339A1 Nucleotide sequences encoding maize rad51
11/22/2000EP1053338A1 Alteration of amino acid compositions in seeds
11/22/2000EP1053337A1 Nucleic acid comprising the sequence of a promoter inductible by stress and a gene sequence coding for a stilbene synthase
11/22/2000EP1053336A1 Promoter inductible in plants, sequence incorporating same and resulting product
11/22/2000EP1053335A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
11/22/2000EP1053334A1 Plant alkaline and neutral invertases
11/22/2000EP1053333A1 Single-chain polypeptides comprising creatine kinase m and creatine kinase b
11/22/2000EP1053332A1 Protein
11/22/2000EP1053331A2 A novel fungal protein critical for expression of fungal proteins
11/22/2000EP1053330A2 Identification, production and use of staphylokinase derivatives with reduced immunogenicity and/or reduced clearance
11/22/2000EP1053329A1 RECOMBINANT LIPIDATED PsaA PROTEIN, METHODS OF PREPARATION AND USE
11/22/2000EP1053328A2 Plant having altered environmental stress tolerance
11/22/2000EP1053327A1 Nucleotide sequences encoding the tomato light hypersensitive phenotype, encoded proteins and uses thereof
11/22/2000EP1053325A2 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination
11/22/2000EP1053324A1 Novel cystine knot protein and materials and methods for making it
11/22/2000EP1053323A2 Human receptor proteins
11/22/2000EP1053322A1 Wnt-10a
11/22/2000EP1053321A1 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same
11/22/2000EP1053320A2 Human transport-associated molecules
11/22/2000EP1053319A2 Human genes and gene expression products ii
11/22/2000EP1053318A2 Cdnas encoding secreted proteins
11/22/2000EP1053317A1 Use of ribozymes for functionating genes
11/22/2000EP1053316A1 Nucleic acids provided for modulating cellular activation
11/22/2000EP1053313A1 Optimized antisense oligonucleotides complementary to dna methyltransferase sequences
11/22/2000EP1053312A2 Optimization of immunomodulatory properties of genetic vaccines
11/22/2000EP1053311A2 Compositions and methods for using a lysing matrix for isolating dna